Autonomic Determinants of Orthostatic Tolerance
Autonomic Determinants of Orthostatic Tolerance
批准号:
7252842
负责人:
DAVID HERLIE ROBERTSON
金额:
$31.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2012-04-30
关键词:
AddressAgeAttenuatedAutonomic nervous systemBalloon DilatationBiological ModelsBlood PressureCALCA geneCalcitonin Gene-Related PeptideCardiovascular systemDailyDependencyDiagnosticDiseaseDopamineDopamine-beta-monooxygenaseElectrolytesHealthHistamine H1 AntagonistsHumanIndividualIngestionLifeMediatingMixed Function OxygenasesMolecularMusNatureNerveNoiseNorepinephrineOlder PopulationOralPharmaceutical PreparationsPhenylpropanolaminePurposeRegulationResearch PersonnelS100A12 geneSerotoninSignal TransductionSourceStimulusStomachSubstance PSympathetic Nervous SystemTherapeuticUpper armVariantVascular resistanceWaterWorkage relatedautonomic reflexbasehuman S100A12 proteinhuman subjectmouse modelpreventprogramsresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oral ingestion of water greatly elevates blood pressure in individuals with impaired autonomic reflexes. While
the effect averages 30-40 mmHg, there is large interindividual variation with occasional increases of 100
mmHg. We were initially startled by the magnitude of this response, but others have now replicated it and
confirmed its magnitude. An effect is also found in treated hypertensive subjects and in normal subjects,
albeit it at smaller magnitude. We have also found that ingestion of water potentiates the effect of the pressor
drug phenylpropanolamine (PPA). In view of its magnitude and robustness, the pressor response to water
may signal an important but heretofore unrecognized mechanism at work in human cardiovascular regulation
both in health and disease. The water response may have important diagnostic and therapeutic implications.
In particular, it may be the major unrecognized determinant of noise in blood pressure assessment in the
older population, and might possibly be a source of interindividual and intraindividual variation in orthostatic
tolerance.
The purpose of this proposal is to address the mechanism of the cardiovascular effect of water ingestion,
and address the basis of interindividual variation in this gastropressor response. We seek to understand if
the sympathetic nervous system is mediating water's pressor response in Specific Aim 1. In Specific Aim 2,
we try to determine the macroscopic stimulus underlying the response. In Specific Aims 3 and 4, we address
potential efferent mechanisms at a more molecular level in both human subjects and in a mouse model
system. Finally in Specific Aim 5 we try to determine the basis of the age dependency of the pressor
response to water.
Although water is a part of daily life, we believe the gastropressor response we have observed may have
important consequences in health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADMINISTRATIVE CORE
-
批准号:8147954
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Echocardiograph and Vascular Doppler
-
批准号:7794037
-
项目类别:
-
资助金额:$20.14万
-
财政年份:2010
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
AUTONOMIC DETERMINANTS OF ORTHOSTATIC TOLERANCE
-
批准号:8147945
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2010
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8136818
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7680534
-
项目类别:
-
资助金额:$125.95万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
training - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7901217
-
项目类别:
-
资助金额:$7.81万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8327851
-
项目类别:
-
资助金额:$121.56万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8150403
-
项目类别:
-
资助金额:$122.62万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8765054
-
项目类别:
-
资助金额:$20.95万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:9146407
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
NATURAL HISTORY STUDY
-
批准号:8932316
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Administrative unit - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7901219
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7925727
-
项目类别:
-
资助金额:$122.15万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8538516
-
项目类别:
-
资助金额:$121.73万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Administrative Core
-
批准号:7252848
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2007
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
THE GENETIC BASIS OF AUTONOMIC DYSFUNCTION
-
批准号:7605552
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
AUTONOMIC SCREENING
-
批准号:7605565
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
THE GENETIC BASIS OF AUTONOMIC DYSFUNCTION
-
批准号:7731377
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
AUTONOMIC SCREENING
-
批准号:7731390
-
项目类别:
-
资助金额:$0.28万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
AUTONOMIC SCREENING
-
批准号:7375636
-
项目类别:
-
资助金额:$23.45万
-
财政年份:2005
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: